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Abstract 
Background: Soft tissue dedifferentiated leiomyosarcoma with heterologous osteosarcomatous component is an 
extremely rare entity described in only few cases in the literature.
Case presentation: We report the case of a 65-year-old male patient who, after initial inadequate surgery of a 
tumor of the left forearm, developed local recurrence that was treated with neoadjuvant chemotherapy, surgery and 
postoperative radiation therapy. Histologically the tumor showed an abrupt separation of two different patterns. One 
component consisted of interlacing fascicles of spindle cells with cigar-shaped nuclei strongly positive for smooth 
muscle actin, desmin and H-caldesmon. The other component consisted of a high-grade pleomorphic sarcoma 
with osteoid and chondroid matrix production, which positive for SATB2. Thus, a final diagnosis of dedifferentiated 
leiomyosarcoma was rendered. Fifteen months after treatment, the patient presented further local and distant relapse 
with pulmonary metastases and died 23 months after the first presentation.
Discussion and conclusions: Dedifferentiated leiomyosarcoma is a highly malignant neoplasm with a poor out-
come. Extensive sampling of soft tissue leiomyosarcomas is recommended to detect possible dedifferentiated areas 
as they represent a crucial prognostic parameter.
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Background
Leiomyosarcoma (LMS) is an aggressive soft tissue sar-
coma that accounts for about 7 to 10% of all soft tissue 
sarcomas and usually occurs in adult and elderly patients 
[1]. The most common involved site is the retroperito-
neum [2], but it can also affect internal organs (e.g. uterus 
or stomach), whereas localization at the limbs is unusual 
[3]. Moreover, sinonasal tract LMSs are exceptionally 
rare with no more than 100 cases reported in the English 
literature [4]. LMS can also occur in bone, as primary or 
secondary tumor localization from distant sites, although 
the former is rare, with about 0.7% incidence of all pri-
mary malignant bone tumors [5].
The term ‘dedifferentiated leiomyosarcoma’ was first 
used by Schmookler and Lauer in 1983 [6] and refers 
to a tumor morphologically characterized by an abrupt 
transition from classic leiomyosarcoma to high-grade 
sarcoma which does not express immunohistochemical 
muscular markers. In rare cases, the non-myogenic com-
ponent of the tumor presents heterologous differentia-
tion. Here we describe a case of a leiomyosarcoma with 
an osteosarcomatous dedifferentiated component and we 
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Case presentation
A 65-year-old man came to our observation with a 
solid-elastic mass of about 4.5 cm maximum diameter 
on the proximal region of the left forearm, ulnar side, 
that appeared hypomobile on the underline planes. 
He reported being affected by this “bump” for at least 
20  years, but it had recently shown a rapid growth. 
Furthermore, he reported having already undergone 
another excision in local anesthesia after an ultrasound 
examination about 1  year before at another hospital. 
An X-ray of the forearm showed a soft tissue mass with 
irregular calcifications (Fig. 1) and CT scan of the limb 
confirmed this finding. Magnetic Resonance Imaging 
(MRI) showed a soft tissue mass arising in the subcu-
tis and involving the skin and the subfascial and mus-
cular planes, with partial invasion of wrist and fingers 
flexor muscles and partially surrounding the bone (lat-
eral side of the ulna). The mass was isointense to mus-
cle in T1-weighted sequence (Fig. 2a), hyperintense on 
T2-weighted sequence (Fig. 2b), with contrast medium 
enhancement on T1-weighted sequence (Fig.  2c) and 
highly vascular (Fig. 3). Staging exams (total body Com-
puted Tomography scan and Positron Emission Tomog-
raphy scan), showed no other tumor localizations.
After preoperative needle biopsy, surgical excision of 
the tumor was performed, including skin (with the scar 
of the previous surgery), fascia, muscles and a portion 
of the ulna. Reconstruction was performed with plate, 
Fig. 1 X-ray of the forearm showing a soft tissue tumor with areas of 
calcification (arrows)
Fig. 2 Magnetic Resonance Imaging (MRI) showing a soft tissue mass 
in the subcutis. The lesion is isointense to muscle in T1-weighted 
sequence (a), hyperintense on T2-weighted sequence (b), and shows 
contrast medium enhancement on T1-weighted sequence (c)
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screws and cement and coverage with a microsurgical 
rotation flap.
Gross examination of the surgical specimen revealed a 
solid white neoplasm with a maximum diameter of 6 cm 
in the soft tissues. Histologically, the tumor showed two 
different, abruptly separated components (Fig.  4). One 
consisted of a proliferation of atypical spindle or ovoid 
cells with cigar-shaped nuclei and eosinophilic cytoplasm 
arranged in long interlacing fascicles, an appearance con-
sistent with leiomyosarcoma (Fig.  5). The other compo-
nent consisted of atypical pleomorphic cells producing 
osteoid matrix in disorganized trabeculae with focal cal-
cification (Fig.  6). Areas of cartilage matrix production 
were identified as well.
Immunohistochemically, areas with leiomyosarcoma-
tous appearance were strongly positive for alpha smooth 
muscle actin (Fig. 7a) and desmin (Fig. 7b), whereas the 
osteosarcomatous component was negative. Both com-
ponents were negative for cytokeratins (AE1/AE3 and 
CAM5.2), EMA, S100 protein, CD34 and CD31. SATB2, 
a marker of osteoblastic differentiation was positive only 
in the osteosarcomatous component, whereas leiomyo-
sarcoma areas were negative (Fig. 7c, d).
The final diagnosis was leiomyosarcoma grade 2, 
according to the French Federation of Comprehensive 
Cancer Centers (FNCLCC) grading system [7] with areas 
of high-grade osteosarcoma (so-called dedifferentiated 
leiomyosarcoma). The tumor infiltrated the dermis, the 
subcutis and the striated muscle. Surgical margins were 
free of tumour. The review of the histologic slides from 
the previous surgical excision showed similar histo-
logical aspects, although the tumor consisted mainly of 
leiomyosarcoma with a very limited osteosarcomatous 
component.
Fig. 3 Maximum intensity projections with dynamic contrast 
enhanced magnetic resonance imaging (DCE-MRI) showing high 
vascularization in the arterial phase
Fig. 4 Low power view showing the two abruptly separated 
components of the tumor. Well-differentiated leiomyosarcoma is 
shown in the lower and high-grade osteosarcoma in the upper right 
(40×)
Fig. 5 Well-differentiated leiomyosarcoma consisting of spindle cells 
arranged in intersecting fascicles (200×)
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After the surgical treatment, the patient received three 
cycles of high-dose adjuvant chemotherapy with adria-
mycin and iphosphamide and local sequential radiother-
apy (66 Gy). After an interval of 15 months, MRI showed 
multiple local recurrences at the site of previous exci-
sions and a PET CT total body scan highlighted bilateral 
pulmonary nodules, for which he underwent a new cycle 
of chemotherapy with gentamicin. The patient died after 
23  months from presentation due to the progression of 
the disease.
Discussion and conclusions
Even if there is no consensus regarding the exact defi-
nition of dedifferentiated leiomyosarcoma, it may be 
described as a well-differentiated tumor showing typical 
features of a smooth muscle neoplasm with a high-grade 
undifferentiated pleomorphic sarcoma component lack-
ing expression of muscle markers.
Dedifferentiation is a well-known occurrence in lipo-
sarcoma and chondrosarcoma, but this phenomenon 
has been only rarely reported in LMS. In most cases, 
Fig. 6 High-grade osteosarcoma consisting of highly atypical cells 
with osteoid matrix production (a; 200×). In other areas neoplastic 
cells produced cartilage matrix (b; 100×)
Fig. 7 The leiomyosarcoma component (on the right in a and b) 
is positive for alpha smooth muscle actin (a, 40×; inset 400×) and 
desmin (b, 100×), whereas the osteosarcoma component (on the left 
in a and b) is negative. SATB2 was positive in the nuclei of neoplastic 
cells in the osteosarcoma component (c, 400×) and negative in the 
leiomyosarcoma (d, 400×)
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dedifferentiated LMS presents discrete transition 
from well-differentiated smooth muscle morphology 
to high-grade pleomorphic morphology with loss of 
smooth muscle differentiation [8]. Only exceptionally 
the dedifferentiated component shows heterologous 
osteosarcomatous differentiation, and review of the lit-
erature revealed only four previously reported extrau-
terine tumors (Table 1). The search of the literature also 
included the term ‘malignant mesenchymoma’ that has 
been abandoned because it is ambiguous.
The first case was a 71-year-old man who underwent 
resection of an intramuscular lesion of the leg, which 
had rapidly enlarged in the preceding 8 weeks [9]. The 
tumour was excised widely and postoperative local 
radiotherapy was administered. A local recurrence and 
a solitary pulmonary metastasis were excised 8 and 
9 months later respectively. The patient died of dissem-
inated disease 22 months after initial excision [9].
Grabellus et al. [10] studied a soft tissue tumor of the 
right groin region of a 35-year-old woman and an initial 
diagnosis of high grade LMS was made. Lung metas-
tases were discovered 6  months after the first surgical 
procedure and 7 months later, the tumor showed local 
recurrence. Histologically, the recurrence showed high 
cellularity and was composed by round irregular to 
pleomorphic cells with high mitotic activity. Neoplas-
tic osteoid was deposited in a lacy, trabecular pattern 
and was focally mineralized. The tumor cells resembled 
malignant osteoblasts.
The large series of 18 dedifferentiated LMSs reported 
by Chen et al. [8] included a retroperitoneal mass com-
posed by well-differentiated LMS with numerous oste-
oclastic giant cells and heterologous osteosarcomatous 
differentiation with malignant osteoid formation. The 
patient was a 66-year old man treated with neoadjuvant 
radiation prior to surgical excision followed by chem-
otherapy, but he developed hepatic metastases and 
died of disease after 8  months. One further retroperi-
toneal LMS in this series presented benign-appearing 
bone and cartilage. This patient was alive with disease 
37 months after presentation.
Feeley et  al. [11] described a 60-year old man with 
a LMS in the left thigh. The lesion was resected but he 
presented 2  years later with pulmonary relapse and, 
18  months later, with metastases in the occipital lobe. 
This lesion showed extensive osteoid deposition sur-
rounded by pleomorphic, mitotically active spindle cells, 
consistent with osteosarcomatous differentiation. This is 
considered an unusual pattern of tumour progression, 
in which a well-differentiated LMS developed divergent 
osteosarcomatous differentiation in the recurrence.
The main clinical and histological differential diagnosis 
is with myositis ossificans. This benign lesion presents a 
characteristic zonal growth pattern, with a central area 
that consists of a nodular fasciitis-like proliferation of 
bland spindle cells, and progressive deposition of oste-
oid matrix in the periphery. Malignant bone forming 
tumors of the soft tissues, including the present case, lack 
this orderly growth pattern and usually present marked 
cytologic atypia. Another entity that can be considered 
in the differential diagnosis is dedifferentiated liposar-
coma with heterologous smooth muscle and osteo-chon-
droblastic differentiation. This possibility was excluded 
because there was no evidence of a well-differentiated 
liposarcoma component in both the first specimen and 
in the recurrence, and in addition the tumor was nega-
tive for MDM2 and CDK4. The possibility that the lesion 
represents a soft tissue osteosarcoma in which spindle 
cell areas show features of leiomyosarcoma or myofi-
brosarcoma was also evaluated, but it seemed unlikely 
because the two components were always sharply sepa-
rated, a feature more consistent with the concept of 
dedifferentiation.
Considering all the cases reported, the average age is 
60 years, with a clear male predominance (4:1). It is very 
important to notice that all the 5 patients had local recur-
rences and developed distant metastases despite aggres-
sive treatments. In 3 patients the outcome was fatal 
(death at 8, 22 and 23 months after surgical excision) due 
to the progression of the disease, while no clinical follow-
up was detailed for the remaining 2 patients. These data 
confirm that dedifferentiated LMS of the soft parts is a 
highly aggressive tumor. According to the literature, these 
Table 1 Summary of the salient clinico-pathologic features of dedifferentiated leiomyosarcomas with osteosarcomatous 
elements of the peripheral soft tissue reported in the literature
Case n. Age Sex Primary site Local 
recurrence
Metastases Status References
1 71 M Leg Yes Lung Deceased after 22 months [9]
2 35 F Groin Yes Lung Unknown [10]
3 66 M Retroperitoneum Yes Liver Deceased after 8 months [8]
4 60 M Thigh Yes Occipital and lung Unknown [11]
5 65 M Forearm Yes Lung Deceased after 23 months Present case
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neoplasms present 50% to 65.2% of mortality and 89% of 
incidence of metastasis [12, 13]. It has also been reported 
that the loss of myogenic markers in LMS may be a sig-
nificant prognostic factor, accounting for a significantly 
higher aggressiveness [14]. For these reasons, extensive 
sampling is recommended in soft tissue LMS in order to 
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